Skip to content
buyWeak cluster of 2

Matthew B. Murphy bought $13k of NAUT

General Counsel at Nautilus Biotechnology, Inc.. 20,000 shares at an average of $0.64, traded Sep 4, 2025, filed Sep 5, 2025.

Conviction score
29
Value
$13k
20,000 shares
Holdings after
74,140
+37% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Officer
    +15
  • Trade size
    $13k at market
    0
  • Relative to holdings
    Holdings up 37%
    +6
  • Price context
    No price history yet
    0
  • Cluster
    2 insiders buying within 14 days
    +8
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001865778-25-000003, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Sep 4, 2025POpen-market purchase
Common Stockindirect: See Footnote
+20,000$0.64$13k74,140Sep 5, 2025

Related signals

Other insiders at Nautilus Biotechnology, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
23Weak
NAUTbuy
Nautilus Biotechnology, Inc.
Kentaro Suzuki
Chief Marketing Officer
$5,960
4,000 shares
-
44Moderate
NAUTbuy 2
Nautilus Biotechnology, Inc.
Sujal M Patel
CEO, President, and Secretary
$136k
200,000 shares
+2%
28Weak
NAUTbuy
Nautilus Biotechnology, Inc.
Anna Mowry
CFO and Treasurer
$11k
15,000 shares
+22%
10Weak
NAUTbuy
Nautilus Biotechnology, Inc.
Parag Mallick
Chief Scientist
$9,885
13,500 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Matthew B. Murphy bought $13k of NAUT | InsiderTell